{"filing":{"accession_number":"0001104659-26-092003","cik":"0001083446","ticker":"ASTH","company_name":"Astrana Health, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"tm2622348d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465926092003/tm2622348d1_8k.htm"},"events":[{"id":25431,"run_id":23083,"accession_number":"0001104659-26-092003","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Astrana Health issued a press release on August 6, 2026 announcing financial results for Q2 2026 and the six months ended June 30, 2026, reporting revenue of $972.5 million (up 49% YoY), net income of $18.5 million (up 81% YoY), and adjusted EBITDA of $68.9 million (up 43% YoY), along with updated 2026 guidance. A conference call and earnings presentation were furnished to discuss the results.","company_name":"Astrana Health, Inc.","ticker":"ASTH","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26260,"accession_number":"0001104659-26-092003","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Astrana Health's financial results for Q2 2026 and six months ended June 30, 2026. The filing explicitly states \"On August 6, 2026, Astrana Health, Inc. issued a press release announcing its financial results for the three and six months ended June 30, 2026\" under Item 2.02 (Results of Operations and Financial Condition). The press release reports revenue of $972.5 million (up 49% YoY), net income of $18.5 million (up 81% YoY), and adjusted EBITDA of $68.9 million (up 43% YoY), along with updated 2026 guidance. This is a material disclosure affecting investor assessment of the registrant's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:41:24.231245+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26261,"accession_number":"0001104659-26-092003","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 discloses a conference call to discuss \"the Company's financial results for the three and six months ended June 30, 2026,\" with an earnings presentation furnished as Exhibit 99.2. The attached press release (EX-99.1) reports Q2 2026 results including revenue of $972.5 million (up 49% YoY), net income of $18.5 million (up 81% YoY), and adjusted EBITDA of $68.9 million (up 43% YoY), along with updated 2026 guidance. This is a standard earnings release disclosure material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:41:24.231245+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26260,"accession_number":"0001104659-26-092003","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Astrana Health's financial results for Q2 2026 and six months ended June 30, 2026. The filing explicitly states \"On August 6, 2026, Astrana Health, Inc. issued a press release announcing its financial results for the three and six months ended June 30, 2026\" under Item 2.02 (Results of Operations and Financial Condition). The press release reports revenue of $972.5 million (up 49% YoY), net income of $18.5 million (up 81% YoY), and adjusted EBITDA of $68.9 million (up 43% YoY), along with updated 2026 guidance. This is a material disclosure affecting investor assessment of the registrant's financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:41:24.231245+00:00","company_name":"Astrana Health, Inc.","ticker":"ASTH","filing_date":"2026-08-06"},{"id":26261,"accession_number":"0001104659-26-092003","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 7.01 discloses a conference call to discuss \"the Company's financial results for the three and six months ended June 30, 2026,\" with an earnings presentation furnished as Exhibit 99.2. The attached press release (EX-99.1) reports Q2 2026 results including revenue of $972.5 million (up 49% YoY), net income of $18.5 million (up 81% YoY), and adjusted EBITDA of $68.9 million (up 43% YoY), along with updated 2026 guidance. This is a standard earnings release disclosure material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:41:24.231245+00:00","company_name":"Astrana Health, Inc.","ticker":"ASTH","filing_date":"2026-08-06"}]}